FIELD: pharmaceutical chemistry. SUBSTANCE: to inhibit endometriosis, invention provides antiestrogens with following general formula: , wherein R1 and R3, independently, are hydrogen atom, methyl, -CO-C1-C6-alkyl, or optionally substituted -CO-phenyl; R2 is pyrrolydino or piperidine group; or pharmaceutically acceptable salts thereof. EFFECT: enlarged assortment of antiestrogen drugs. 4 cl, 2 dwg, 4 ex
Authors
Dates
2000-10-10—Published
1994-10-13—Filed